The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Katrina Armstrong

Department of Medicine

University of Pennsylvania School of Medicine




Name/email consistency: high



  • Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA. 2000 - 2011
  • Department of Medicine, University of Pennsylvania School of Medicine, The University of Pennsylvania Cancer Center, Leonard Davis Institute of Health Economics, USA. 2000


  1. Racial differences in surgeons and hospitals for endometrial cancer treatment. Armstrong, K., Randall, T.C., Polsky, D., Moye, E., Silber, J.H. Med. Care (2011) [Pubmed]
  2. Differences in the patterns of health care system distrust between blacks and whites. Armstrong, K., McMurphy, S., Dean, L.T., Micco, E., Putt, M., Halbert, C.H., Schwartz, J.S., Sankar, P., Pyeritz, R.E., Bernhardt, B., Shea, J.A. J. Gen. Intern. Med (2008) [Pubmed]
  3. Racial/ethnic differences in physician distrust in the United States. Armstrong, K., Ravenell, K.L., McMurphy, S., Putt, M. Am. J. Public. Health (2007) [Pubmed]
  4. Distrust of the health care system and self-reported health in the United States. Armstrong, K., Rose, A., Peters, N., Long, J.A., McMurphy, S., Shea, J.A. J. Gen. Intern. Med (2006) [Pubmed]
  5. Patient preferences can be misleading as explanations for racial disparities in health care. Armstrong, K., Hughes-Halbert, C., Asch, D.A. Arch. Intern. Med. (2006) [Pubmed]
  6. Prescription of tamoxifen for breast cancer prevention by primary care physicians. Armstrong, K., Quistberg, D.A., Micco, E., Domchek, S., Guerra, C. Arch. Intern. Med. (2006) [Pubmed]
  7. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Armstrong, K., Micco, E., Carney, A., Stopfer, J., Putt, M. JAMA (2005) [Pubmed]
  8. Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1/2 mutations. Armstrong, K., Weber, B., Ubel, P.A., Peters, N., Holmes, J., Schwartz, J.S. J. Clin. Oncol. (2005) [Pubmed]
  9. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. Armstrong, K., Schwartz, J.S., Randall, T., Rubin, S.C., Weber, B. J. Clin. Oncol. (2004) [Pubmed]
  10. Measuring adherence to mammography screening recommendations among low-income women. Armstrong, K., Long, J.A., Shea, J.A. Prev. Med (2004) [Pubmed]
  11. Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. Armstrong, K., Weber, B., Stopfer, J., Calzone, K., Putt, M., Coyne, J., Schwartz, J.S. Am. J. Med. Genet. A (2003) [Pubmed]
  12. Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. Armstrong, K., Weber, B., FitzGerald, G., Hershey, J.C., Pauly, M.V., Lemaire, J., Subramanian, K., Asch, D.A. Am. J. Med. Genet. A (2003) [Pubmed]
  13. Effect of framing as gain versus loss on understanding and hypothetical treatment choices: survival and mortality curves. Armstrong, K., Schwartz, J.S., Fitzgerald, G., Putt, M., Ubel, P.A. Med. Decis. Making (2002) [Pubmed]
  14. What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Armstrong, K., Stopfer, J., Calzone, K., Fitzgerald, G., Coyne, J., Weber, B. Genet. Test. (2002) [Pubmed]
  15. Barriers to influenza immunization in a low-income urban population. Armstrong, K., Berlin, M., Schwartz, J.S., Propert, K., Ubel, P.A. Am. J. Prev. Med (2001) [Pubmed]
  16. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk. Armstrong, K., Chen, T.M., Albert, D., Randall, T.C., Schwartz, J.S. Obstet. Gynecol (2001) [Pubmed]
  17. Assessing the risk of breast cancer. Armstrong, K., Eisen, A., Weber, B. N. Engl. J. Med. (2000) [Pubmed]
  18. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Armstrong, K., Popik, S., Guerra, C., Ubel, P.A. Med. Decis. Making (2000) [Pubmed]
  19. Factors associated with decisions about clinical BRCA1/2 testing. Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., Weber, B. Cancer Epidemiol. Biomarkers Prev. (2000) [Pubmed]
WikiGenes - Universities